An industry snapshot dated 6 November reports progress in dairy vaccination while showing that clinical disease remains present on many monitored farms.
South Africa's dairy-sector foot-and-mouth disease dashboard reports 1,022,676 cows vaccinated in its 6 November update, an increase of 11,445 on the previous weekly figure. The same snapshot lists 175 confirmed farms, including 128 still recorded as clinically affected.
The figures come from the Milk Producers' Organisation information displayed on the Agri SA-hosted dashboard. They describe that dairy monitoring stream at a stated reporting date. They should not be presented as a complete national count covering every livestock species, farming system or outbreak investigation.
For dairy producers, the update combines two different measures: the reach of vaccination activity and the continuing clinical burden recorded on farms. A higher vaccination total does not, by itself, establish that transmission has stopped or that every vaccinated animal has completed a required course.
Read the categories carefully
The dashboard places 47 of the 175 confirmed farms in a category described as no longer clinically affected. That distinction is useful, but it is narrower than a declaration that those properties have been released from quarantine or that infection has been eradicated.
Vaccination, clinical recovery and official disease-control status answer different questions. The published total does not provide enough information to calculate the proportion of all eligible dairy cattle fully protected. Nor does it supply a basis for comparing vaccine effectiveness between provinces.
Agri Online has not independently audited the underlying farm returns. The dashboard is an attributed industry record, rather than a separate verification of each animal or property. Keeping its date and scope attached to the numbers makes the update useful without overstating what it can prove.
Why the distinction matters for milk production
The World Organisation for Animal Health describes FMD as a highly contagious disease of cloven-hoofed animals. Production losses, including reduced milk output, can be part of its agricultural impact. A farm's operational recovery can therefore involve more than the disappearance of visible signs.
WOAH's disease guidance also explains why clinical observations alone are insufficient to settle every suspected case: other vesicular diseases can resemble FMD, and laboratory confirmation is important. A report of suspicious signs should enter the veterinary assessment process rather than become an informal diagnosis shared as fact.
Its prevention guidance places emphasis on biosecurity, including controls around access and the movement of potentially contaminated people, vehicles and equipment. Those measures remain relevant alongside vaccination. The international guidance does not establish the current movement permission for a particular South African farm.
Use the responsible veterinary channel
South Africa's official FMD portal provides channels connected to vaccination reporting and requests for veterinary services. Producers should use the current official process and their responsible veterinarian when checking what is required for their own animals and circumstances.
An industry dashboard is valuable for following broad progress, but it cannot issue a permit, clear a consignment or replace a farm-specific instruction. Decisions about animals, milk collection arrangements or movements require the applicable veterinary direction and current requirements, rather than an assumption drawn from a national-looking total.
The MPO also lists animal-health and biosecurity support among its producer services. This provides a route to sector information, while official disease-control decisions remain with the relevant authorities. Neither service listing nor dashboard entry should be read as an individual farm's clearance document.
A dated measure of progress
The November snapshot offers an important marker of the scale reached by dairy vaccination reporting. Its most useful message is that substantial activity and continuing clinical disease can appear in the same update. Those observations do not contradict one another.
The next comparable release will be needed to establish how these categories move after 6 November. Until then, the figures should retain that date in headlines, captions and social summaries. They support an account of recorded progress in the dairy sector, with clear limits on coverage and interpretation, rather than a claim that South Africa's FMD emergency has ended.

